Archive for May, 2012

FDA Advisory Panel Votes to Approve New Obesity Drug

May 10, 2012 — In an 18-4 decision with one abstention, a panel of experts voted to approve the first new obesity drug in over a decade. Lorcaserin, made by Arena Pharmaceuticals, was voted down when it came before the FDA in 2010 because of certain safety risks and a feeling the drug was not effective enough in helping […]

Institute of Medicine Report Lays Out Strategy for Fighting Obesity

May 8, 2012 — May 8, 2012 — The Institute of Medicine (IOM) report, laid out today at the U.S. Centers for Disease Control and Prevention’s "Weight of the Nation" conference, says the progress the U.S. has been making in fighting obesity has been too slow and that more drastic changes are required.